The COVID-19 pandemic is over, though of course the virus is still with us. Looking back, how should we judge the government response? What did we do right, and what could be done better?
Articles on PCR testing
Displaying 1 - 20 of 21 articles
Research shows that rapid antigen tests are performing as well at detecting the most recent dominant variants as they did with the earliest strains in the COVID-19 pandemic.
Here’s what we know from the limited data publicly available.
England has stopped offering free COVID tests, amid a large surge in cases. Here’s what that could mean.
Understanding the difference between COVID tests can help explain why the rules keep changing.
Even minor reductions in COVID transmission rates due to early isolation would justify the additional costs associated with the policy.
The prime minister’s inflexibility on the home-testing COVID tests is beyond curious - especially in an election year.
Knowing when and how often to use rapid tests is key to getting an accurate picture of your COVID-19 status.
The reason for these results has yet to be confirmed – but maths may explain the phenomenon.
Who’s a good doggie? Sniffer dogs might one day be able to screen people for COVID-19 in large crowds. But not when they’re hungry or need a good lie down.
Even if you’re vaccinated, you still need to come forward for COVID testing, even if you have the mildest symptoms.
Over the approaching holidays, people around the world will want to travel to see friends and family. Getting tested for the coronavirus can make this safer, but testing alone is not a perfect answer.
A man in the Northern Territory recently received a “weak positive” test result for COVID-19. Understanding how coronavirus tests work shows us why this can happen from time to time.
The swab test may be uncomfortable, but it is perfectly safe.
A new test, which can diagnose COVID-19 in 15 minutes, has been approved by the TGA. But it’s no silver bullet.
The prime minister big new plan is a flawed policy in search of the science to back it up.
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
Answering this is not as straightforward as you might think. But a careful analysis of the data suggests the news is not great.
COVID-19 tests rely on a process developed at a biotech company co-founded by a Canadian. Canada’s current testing expertise needs to be channelled to prepare for the next wave, and the next pandemic.
Ideally everyone could get tested frequently for the coronavirus. No state is close to achieving this, but some are doing better than others. What are the challenges in meeting demand for testing?
Top contributors
-
Professor of Mathematical Biology and Public Engagement, University of Bath
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Professor of Public Health, University of Sheffield
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Senior Research Officer, National Centre for Immunisation Research and Surveillance; PhD candidate
-
Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Assistant Professor of Pediatrics, Emory University
-
Professor of Rhinology and Olfactology, University of East Anglia
-
Associate Professor in Health Economics, Flinders University
-
Professor of Health Economics, Flinders University
-
Assistant Professor of Medicine, UMass Chan Medical School
-
Professor of Infectious Diseases and Global Health, University of Sydney
-
Associate Professor of Medicine, Michigan State University
-
Professor, Australian Studies Institute, Australian National University